Sage Journals: Discover world-class research

Abstract

Pyoderma Gangrenosum is cutaneous manifestation of a systemic problem that should be systematically diagnosed and managed with care. When such lesions appear on legs, it is important to study and treat the systematic problem.

Keywords

pyoderma gangrenosum ulcerative colitis arthritis corticosteroids immunosuppressives graftskin

Get full access to this article

View all access options for this article.

References

Burnsting LA , Goeckrman WH , O’Leary PA . Pyoderma (ecthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol 1930;22:655-690.

Johnson ML , Wilson HTH . Skin lesions in ulcerative colitis. Gut 1969;10:255-263.

Mir-Madjlessi SH , Taylor JS , Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol 1985;80:615-620.

Samitz MH , Greenberg MS. Skin lesion in association with ulcerative colitis. Gastroenterology 1951;19:476-479.

Powell FC , Schroeter AL , Su WPD , et al. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985;55:173-186.

Powell FC , Perry HO. Pyoderma gangrenosum in childhood. Arch Dermatol 1984;120:757-761.

Powell FC , Su WPD , Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996;34:395-409.

Greenstein AJ , Janowitz HD , Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine (Balt) 1976;55:401-412.

Cox NH , Peebler-Brown PA , Mackie RM. Pyoderma gangrenosum occurring 10 years after procto-colectomy for ulcerative colits. Br J Hosp Med 1986;36:363.

10.

Gilman AL , Cohen BA , Urbach , et al. Pyoderma gangrenosum as a manifestation of leukaemia in childhood. Paediatrics 1988;81:846-848.

11.

Ho KK-L , Otridge B , Vandenberg E , et al. Pyoderma gangrenosum, polycythaemia rubra vera and development of leukaemia. J Am Acad Dermatol 1992;27:804-808.

12.

Mahood JM , Senddon IB. Pyoderma gangrenosum complicating non-Hodgkin’s lymphoma. Br J Dermatol 1980;102:233-235.

13.

Kitahama A , Roand PY , Kerstein MD. Pyoderma gangrenosum with cutaneous T-cell lymphoma manifested as lower extremity ulcers: case reports. Angiology 1991;42:498-503.

14.

Jacobs P , Palmer S , Gordon-Smith EC. Pyoderma gangrenosum in myelodysplasia and acute leukaemia. Postgrad Med J 1985;61:689-694.

15.

Harland CC , Millard LG.

Pyoderma gangrenosum—a complication of chronic venous leg ulceration?

Clin Exp Dermatol 1993;18:545-547.

16.

Holt PJA , Davies MG , Sanders KC , et al. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine 1980;59:114-133.

17.

Percival GH. Pyoderma gangrenosum: the histology of the primary lesion. Br J Dermatol 1957;69:130-136.

18.

Rosenberg A. The Schwartzmann phenomenon: a review with a consideration of possible dermatological manifestations. Br J Dermatol 1953;65:389-391.

19.

Meyer K , Gelhorn A , Prudden JF. Lysozyme activity in ulcerative alimentary disease II. Am J Med 1948;5:496-502.

20.

Strongton RB. Enzymatic cytolysis of epithelium by filtrates from patients with ulcerative colitis. J Invest Dermatol 1953;20:353-356.

21.

Delescluse J , Bast C , Achten G. Pyoderma gangrenosum with altered cellular immunity and dermatonecrotic factor. Br J Dermatol 1972;87:529-532.

22.

Marcussen PV. Hypogammaglobulinaemia in pyoderma gangrenosum. J Invest Dermatol 1988;18:574-576.

23.

Berbis P , Mege JL , Capo C , et al. Hypoimmunegloulin E and impaired neutrophil function in a case of pyoderma gangrenosum: effect of Clofamazine. J Am Acad Dermatol 1988;18:574-576.

24.

Lazarus GS , Goldsmith LA , Rocklin RE , et al. Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis. Arch Dermatol 1972;105:46-51.

25.

Nerella P , Damela A , Guido A , et al. Leukocyte chaemotaxis and pyoderma gangrenosum. Int J Dermatol 1985;24:45-47.

26.

Bentley-Phillips CB , Cooper RC , Hallett AF. Pharmacological modulation of neutrophil phagocytic functionin a patient with recurrent sepsis, pyoderma gangrenosum and impaired phagocytosis. Br J Dermatol 1982;106:687-695.

27.

Check IJ , Ellington EP , Moreland A , et al. T-helper-suppressor cell imbalance in pyoderma gangrenosum with relapsing polychondritis and corneal keratolysis. Am J Clin Pathol 1983;80:396-399.

28.

Callen JP. Pyoderma gangrenosum. Lancet 1998;351:581-585.

29.

Dwarakanath AD , Yu LG , Brooks C , et al. Sticky neutrophils, pathergic arthritis and response to heparin in pyoderma gangrenosum complicating ulcerative colits. Gut 1995;37:585-588.

30.

Jones SC , Banks RE , Haider A , et al. Adhesion molecules in inflammatory bowel disease. Gut 1995;36:724-730.

31.

Springer TA. Traffic signals for leukocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.

32.

Ciuffetti G , Lombardini R , Paltriccia R , et al. Human leukocyte-endothelial interactions in peripheral arterial occlusive disease. Eur J Clin Invest 1994;24:65-68.

33.

Chow RKP , Ho VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol 1996;34:1047-1057.

34.

Moschella SL. Pyoderma gangrenoum: a patient successfully treated with intra-lesional injection of steroids. Arch Dermatol 1967;95:121-123.

35.

Jennings JL. Pyoderma gangrenosum: successful treatment with intra lesional steroids. J Am Acad Dermatol 1983;9:575-580.

36.

Gardner LW , Acker DW. Triamcinolone and pyoderma gangrenosum. Arch Dermatol 1972;106:599-600.

37.

Duffill MB. Cyclosporin, azathioprine and local therapy for pyoderma gangrenosum. Australas J Dermatol 1994;35:15-18.

38.

Newell LM , Malkinson FD. Commentary: pyoderma gangrenosum. Arch Dermatol 1982;118:769-773.

39.

Peachy RDG . Pyoderma gangrenosum of scalp. Br J Dermatol 1974;90:106-108.

40.

Sanders CJG , Hulsmans RFHJ . Successful treatment of pyoderma gangrenosum with topical 5-Aminosalicylic acid. Cutis 1993;51:262-264.

41.

Johnson RB , Lazarus GS. Pulse therapy: therapeutic efficacy in the treatment of pyoderma gangrenosum. Arch Dermatol 1982;118:76-84.

42.

Bocanegra TS , Castaneda MD , Espinoza LR , et al. Sudden death after methyl prednisolone pulse therapy (letter). Ann Intern Med 1981;95:122.

43.

Freedman MD , Schhocket AL , Chapel L , et al. Anaphylaxis and intravenous methyl prednisolone administration. JAMA 1981;245: 607-608.

44.

Curley RK , Macfarlane AW , Vickers CFH . Pyoderma gangrenosum treated with cyclosporin A. Br J Dermatol 1985;113: 601-604.

45.

Abu-Elmagd K , Jegasothy BV , Acherman CD , et al. Efficacy of FK506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc 1991;23:3328-3329.

46.

Mazzone A , Cusa C , Mazzucchelli I , et al. Pyoderma gangrenosum complicating ulcerative colitis: an alternative treatment with Iloprost. Curr Ther Res 1999;60:357-362.

47.

de Imus G , Golomb C , Wilkel C , et al. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppressive therapy. J Am Acad Dermatol 2001;44:61-66.